ÂÜÀòÂÒÂ×

Jennifer Dovey has a background in genetics and a Ph.D. in Genetics from Harvard University. Jennifer has held various positions focusing on drug discovery and development in biotech and pharmaceutical companies. Jennifer has experience in leading research projects, developing novel antibody therapies, and managing cross-functional teams. Jennifer has also conducted research on cancer pathways and stem cells during their time as a postdoctoral fellow at the David H. Koch Institute for Integrative Cancer Research @ MIT. Jennifer is currently the Chief Scientific Officer at Triveni Bio.